|
Originally published In Press as doi:10.1074/jbc.M709657200 on February 6, 2008
J. Biol. Chem., Vol. 283, Issue 17, 11689-11699, April 25, 2008
Genome-wide Analysis Identifies Interleukin-10 mRNA as Target of Tristetraprolin*
Georg Stoecklin 1,
Scott A. Tenenbaum¶,
Thomas Mayo ,
Sridar V. Chittur¶,
Ajish D. George¶,
Timothy E. Baroni¶,
Perry J. Blackshear||, and
Paul Anderson
From the
Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, the German Cancer Research Center, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany, the ¶Department of Biomedical Sciences, Gen*NY*Sis Center for Excellence in Cancer Genomics and the Center for Functional Genomics, School of Public Health, University at Albany-SUNY, Rensselaer, New York 12144, and || NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709
Tristetraprolin (TTP) is an RNA-binding protein required for the rapid degradation of mRNAs containing AU-rich elements. Targets regulated by TTP include the mRNAs encoding tumor necrosis factor- , granulocyte-macrophage colony-stimulating factor, interleukin-2 (IL-2), and immediate early response 3. To identify novel target mRNAs of TTP in macrophages, we used a genome-wide approach that combines RNA immunoprecipitation and microarray analysis. A list was compiled of 137 mRNAs that are associated with TTP with an estimated accuracy on the order of 90%. Sequence analysis revealed a highly significant enrichment of AU-rich element motifs, with AUUUA pentamers present in 96% and UUAUUUAUU nonamers present in 44% of TTP-associated mRNAs. We further show that IL-10 is a novel target regulated by TTP. IL-10 mRNA levels were found to be elevated because of a reduced decay rate in primary macrophages from TTP-/- mice. Our study demonstrates the importance of experimental approaches for identifying targets of RNA-binding proteins.
Received for publication, November 27, 2007
, and in revised form, February 4, 2008.
* This work was supported by National Institutes of Health Grants AI-33600 and AI-50167 (to P. A.), National Human Genome Research Institute, National Institutes of Health Grants U01HG004571 and R21HG003679 (to S. A. T.), and a Young Investigators Grant from the Helmholtz Association of German Research Centres (to G. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1-S4 and Figs. S1 and S2.
1 To whom correspondence should be addressed: German Cancer Research Center, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. Tel.: 49-6221-546887; Fax: 49-6221-545891; E-mail: g.stoecklin{at}dkfz.de.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Schaljo, F. Kratochvill, N. Gratz, I. Sadzak, I. Sauer, M. Hammer, C. Vogl, B. Strobl, M. Muller, P. J. Blackshear, et al.
Tristetraprolin Is Required for Full Anti-Inflammatory Response of Murine Macrophages to IL-10
J. Immunol.,
July 15, 2009;
183(2):
1197 - 1206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Alvarez, C. Municio, S. Alonso, M. Sanchez Crespo, and N. Fernandez
The Induction of IL-10 by Zymosan in Dendritic Cells Depends on CREB Activation by the Coactivators CREB-Binding Protein and TORC2 and Autocrine PGE2
J. Immunol.,
July 15, 2009;
183(2):
1471 - 1479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Brennan, Y. Kuwano, N. Alkharouf, P. J. Blackshear, M. Gorospe, and G. M. Wilson
The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis
Cancer Res.,
June 15, 2009;
69(12):
5168 - 5176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Ogilvie, J. R. SternJohn, B. Rattenbacher, I. A. Vlasova, D. A. Williams, H. H. Hau, P. J. Blackshear, and P. R. Bohjanen
Tristetraprolin Mediates Interferon-{gamma} mRNA Decay
J. Biol. Chem.,
April 24, 2009;
284(17):
11216 - 11223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Horner, W. S. Lai, D. J. Stumpo, and P. J. Blackshear
Stimulation of Polo-Like Kinase 3 mRNA Decay by Tristetraprolin
Mol. Cell. Biol.,
April 15, 2009;
29(8):
1999 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|